Methods and compositions for reducing immunosuppression by tumor cells
Abstract:
The present disclosure provides, in part, methods of discovering immunotherapy targets in vivo, therapeutic compositions (e.g., shRNA, immunoresponsive cells expressing shRNA and/or a chimeric antigen receptors (CAR)), and methods of use thereof.
Information query
Patent Agency Ranking
0/0